Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11377441 Covalent inhibitors of KRAS

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 5, 2022

Patent Application Number

16915942

Date Filed

June 29, 2020

Patent Citations

US Patent 10144724 Substituted quinazoline compounds and methods of use thereof

US Patent 10723738 Inhibitors of KRAS G12C mutant proteins

US Patent 10730867 Inhibitors of KRAS G12C mutant proteins

US Patent 10736897 Compounds and methods of use thereof for treatment of cancer

US Patent 10745385 Covalent inhibitors of KRAS

US Patent 10822312 Substituted quinazoline compounds and methods of use

US Patent 10829458 Substituted quinazoline compounds and methods of use thereof

US Patent 10858343 Inhibitors of KRAS G12C mutant proteins

...

Patent Citations Received

US Patent 11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS

0

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

0

Patent Primary Examiner

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11377441 Covalent inhibitors of KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool